Reuters logo
BRIEF-FDA approves Medicines360's SNDA for Liletta to prevent pregnancy for up to four years
August 7, 2017 / 12:11 PM / 4 months ago

BRIEF-FDA approves Medicines360's SNDA for Liletta to prevent pregnancy for up to four years

Aug 7 (Reuters) - Allergan Plc

* FDA approves Medicines360’s SNDA for Liletta (levonorgestrel-releasing intrauterine system) 52 mg to prevent pregnancy for up to four years

* Allergan Plc - ‍FDA approved Medicines360’s SNDA to extend duration of use of Liletta 52 mg for prevention of pregnancy for up to four years​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below